NCT01383590View on ClinicalTrials.gov

Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis

PHASE1CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

October 31, 2011

Primary Completion Date

December 31, 2013

Study Completion Date

December 31, 2013

Conditions
Cat Allergy
Interventions
BIOLOGICAL

Cat-PAD

Intradermal injection 1 x 4 administrations 4 weeks apart.

Trial Locations (1)

K7L 2V7

Kingston General Hospital, Kingston

Sponsors

Collaborators (1)

Adiga Life Sciences, Inc.
All Listed Sponsors
collaborator

Adiga Life Sciences, Inc.

INDUSTRY

lead

Circassia Limited

INDUSTRY

NCT01383590 - Identification of Potential Biomarkers of Peptide Immunotherapy. Part 1 - Proteomics Analysis | Biotech Hunter | Biotech Hunter